Israel Englander Abcam PLC Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $52.6 Million - $102 Million	4,171,269 Added 677.01%	4,787,401 $117 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $2.65 Million - $3.49 Million	203,953 Added 49.48%	616,132 $8.29 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $5.43 Million - $6.63 Million	389,972 Added 1756.08%	412,179 $6.41 Million
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $3.55 Million - $4.45 Million	-265,422 Reduced 92.28%	22,207 $333,000
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $1.7 Million - $2.58 Million	134,055 Added 87.29%	287,629 $4.16 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $2.38 Million - $3.67 Million	153,574 New	153,574 $2.81 Million
Q2 2021 Aug 16, 2021	SELL	$18.47 - $22.11 $590,707 - $707,122	-31,982 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.22 - $24.3 $2.31 Million - $2.92 Million	-120,012 Reduced 78.96%	31,982 $615,000
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $2.77 Million - $3.41 Million	151,994 New	151,994 $3.28 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.